[Sulpiride in psychiatric practice]

Area of Science:

• Pharmacology
• Psychiatry
• Neuroscience

Background:

• Sulpiride, a substituted benzamide, selectively blocks D-2 receptors.
• Its clinical efficacy in various psychiatric conditions requires further elucidation.

Purpose of the Study:

• To evaluate the clinical effectiveness of sulpiride in schizophrenia, anorexia nervosa, and bulimia nervosa.
• To compare sulpiride's efficacy against haloperidol in schizophrenia treatment.

Main Methods:

• Clinical trials assessing sulpiride's effectiveness.
• Comparative analysis with haloperidol for schizophrenia.
• Evaluation in patients with anorexia nervosa and bulimia nervosa.

Main Results:

• Sulpiride demonstrated effectiveness in schizophrenia, particularly for abulic and depressive symptoms without productive features.
• The drug also showed efficacy in psychoaffective psychoses.
• Therapeutic outcomes for anorexia nervosa and bulimia nervosa were not superior to existing treatments.

Conclusions:

• Sulpiride is a valuable therapeutic option for specific presentations of schizophrenia and psychoaffective disorders.
• Its utility in eating disorders like anorexia nervosa and bulimia nervosa is limited compared to other available treatments.